HER2-negative Breast Cancer Clinical Trials in Detroit, Michigan
2 recruitingDetroit, Michigan
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
Metastatic Breast CancerHER2-negative Breast CancerAdvanced Breast Cancer+1 more
RayzeBio, Inc.124 enrolled31 locationsNCT06590857
Recruiting
Not Applicable
A Study of the TheraBionic P1 Device in Breast Cancer
HER2-negative Breast CancerBreast Cancer Stage IBreast Cancer Stage II+2 more
Barbara Ann Karmanos Cancer Institute24 enrolled1 locationNCT07218432